Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge

被引:23
作者
Martin-Escolano, Javier [1 ]
Medina-Carmona, Encarnacion [2 ]
Martin-Escolano, Ruben [1 ]
机构
[1] Univ Granada, Inst Invest Biosanitaria Ibs Granada, Dept Parasitol, Hosp Univ Granada, Granada 18071, Spain
[2] Univ Granada, Dept Phys Chem, Granada 18071, Spain
来源
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 11期
关键词
American trypanosomiasis; Chagas disease; chemotherapy; drug discovery; neglected tropical disease; screening cascade; target product profile; Trypanosoma cruzi; TRYPANOSOMA-CRUZI INFECTIONS; DISCRETE TYPING UNITS; IN-VITRO; GENETIC EXCHANGE; DRUG DISCOVERY; NUCLEOTIDE-SEQUENCES; BRAZILIAN CONSENSUS; RANDOMIZED-TRIAL; ADIPOSE-TISSUE; HEART-DISEASE;
D O I
10.1021/acsinfecdis.0c00353
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chagas disease is a neglected tropical disease and a global public health issue. In terms of treatment, no progress has been made since the 1960s, when benznidazole and nifurtimox, two obsolete drugs still prescribed, were used to treat this disease. Hence, currently, there are no effective treatments available to tackle Chagas disease. Over the past 20 years, there has been an increasing interest in the disease. However, parasite genetic diversity, drug resistance, tropism, and complex life cycle, along with the limited understanding of the disease and inadequate methodologies and strategies, have resulted in the absence of new insights in drugs development and disappointing outcomes in clinical trials so far. In summary, new drugs are urgently needed. This Review considers the relevant aspects related to the lack of drugs for Chagas disease, resumes the advances in tools for drug discovery, and discusses the main features to be taken into account to develop new effective drugs.
引用
收藏
页码:2830 / 2843
页数:14
相关论文
共 129 条
  • [61] Keenan Martine, 2015, Prog Med Chem, V54, P185, DOI 10.1016/bs.pmch.2014.12.001
  • [62] Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
    Khare, Shilpi
    Nagle, Advait S.
    Biggart, Agnes
    Lai, Yin H.
    Liang, Fang
    Davis, Lauren C.
    Barnes, S. Whitney
    Mathison, Casey J. N.
    Myburgh, Elmarie
    Gao, Mu-Yun
    Gillespie, J. Robert
    Liu, Xianzhong
    Tan, Jocelyn L.
    Stinson, Monique
    Rivera, Ianne C.
    Ballard, Jaime
    Yeh, Vince
    Groessl, Todd
    Federe, Glenn
    Koh, Hazel X. Y.
    Venable, John D.
    Bursulaya, Badry
    Shapiro, Michael
    Mishra, Pranab K.
    Spraggon, Glen
    Brock, Ansgar
    Mottram, Jeremy C.
    Buckner, Frederick S.
    Rao, Srinivasa P. S.
    Wen, Ben G.
    Walker, John R.
    Tuntland, Tove
    Molteni, Valentina
    Glynne, Richard J.
    Supek, Frantisek
    [J]. NATURE, 2016, 537 (7619) : 229 - +
  • [63] Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease
    Khare, Shilpi
    Liu, Xianzhong
    Stinson, Monique
    Rivera, Ianne
    Groessl, Todd
    Tuntland, Tove
    Yeh, Vince
    Wen, Ben
    Molteni, Valentina
    Glynne, Richard
    Supek, Frantisek
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6385 - 6394
  • [64] Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
    Kratz, Jadel Mueller
    Garcia Bournissen, Facundo
    Forsyth, Colin J.
    Sosa-Estani, Sergio
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (10) : 943 - 957
  • [65] Drug discovery for chagas disease: A viewpoint
    Kratz, Jadel Muller
    [J]. ACTA TROPICA, 2019, 198
  • [66] Transmission of Trypanosoma cruzi by Heart Transplantation
    Kun, Heather
    Moore, Anne
    Mascola, Laurene
    Steurer, Frank
    Lawrence, Gena
    Kubak, Bernard
    Radhakrishna, Suman
    Leiby, David
    Herron, Ross
    Mone, Tom
    Hunter, Robert
    Kuehnert, Matthew
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (11) : 1534 - 1540
  • [67] Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?
    Lepesheva, Galina I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (12) : 1479 - 1489
  • [68] Putting Infection Dynamics at the Heart of Chagas Disease
    Lewis, Michael D.
    Kelly, John M.
    [J]. TRENDS IN PARASITOLOGY, 2016, 32 (11) : 899 - 911
  • [69] A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
    Lewis, Michael D.
    Francisco, Amanda Fortes
    Taylor, Martin C.
    Kelly, John M.
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2015, 20 (01) : 36 - 43
  • [70] Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
    Lewis, Michael D.
    Francisco, Amanda Fortes
    Taylor, Martin C.
    Burrell-Saward, Hollie
    McLatchie, Alex P.
    Miles, Michael A.
    Kelly, John M.
    [J]. CELLULAR MICROBIOLOGY, 2014, 16 (09) : 1285 - 1300